Cornea/External Disease News

Postoperative pain is the No. 1 complaint among our surgical patients, especially among those undergoing corneal cross-linking, which involves the creation of a 9-mm corneal epithelial defect.

We are still performing too many corneal transplants for keratoconus — and I say that as a cornea transplant surgeon.

Okyo Pharma released new data from its phase 2 trial of OK-101, a lipid conjugated chemerin peptide agonist, which showed a 68% improvement in both conjunctival staining and ocular pain among patients with dry eye disease.

A corneal ulcer refractory to medical management often proceeds to therapeutic penetrating keratoplasty in the late stages.

Hi everyone, welcome to another episode of season two of Our View Healio Vlog, focusing on physician wellness and I'd like to welcome Ashley Brissette. Thank you for joining us.

For the fourth consecutive year, Prevent Blindness has declared June 28 to July 4 as Fireworks Safety Awareness Week, a time to educate the public about the dangers of fireworks.

KIAWAH ISLAND, S.C. — A study presented at Kiawah Eye found no difference in surgical outcomes between endoscopic and external dacryocystorhinostomy in adults and children with nasolacrimal duct obstruction.

The quick answer is, of course, everyone.

We published a peer-reviewed article, “A unification theory for dry eye and blepharitis,” in Clinical Ophthalmology in 2016.

The FDA granted breakthrough therapy and regenerative medicine advanced therapy designations for AURN001 for the treatment of corneal edema secondary to corneal endothelial disease, according to a press release from Aurion Biotech.